SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sang Bong Ahn, Dae Won Jun, Sang Gyune Kim, Sae Hwan Lee, Hyun Phil Shin, Won Hyeok Choe, Ja Kyung Kim, Kyu Sik Jung, Do Young Kim, Jae-Jun Shim, Soo Young Park, Yeon Seok Seo, Won Kim, Jae Il Chung, Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis, European Journal of Internal Medicine, 2015, 26, 4, 292

    CrossRef

  2. 2
    C.-H. Liu, C.-J. Liu, C.-F. Huang, J.-W. Lin, C.-Y. Dai, C.-C. Liang, J.-F. Huang, P.-H. Hung, H.-B. Tsai, M.-K. Tsai, C.-Y. Lee, S.-I. Chen, S.-S. Yang, T.-H. Su, H.-C. Yang, P.-J. Chen, D.-S. Chen, W.-L. Chuang, M.-L. Yu, J.-H. Kao, Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial, Gut, 2015, 64, 2, 303

    CrossRef

  3. 3
    Jeyamani Ramachandran, Ramit Mahajan, Gopal Basu, P. L. Alagammai, Jayashree Sivakumar, Ashish Goel, Priya Abraham, V. Tamilarasi, Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease, Indian Journal of Gastroenterology, 2014, 33, 5, 471

    CrossRef